NanoGroup S.A.

zł 2.25As of Sun 8 Nov 2026, 12:00 UTC
WSE:NNGHealthcare
Country Poland
PE (Fwd) •••
TSR 9Y CAGR (3.92%)
Div yield —
ROE (93.57%)
Biotechnology
Beta (5Y) 0.56
PE TTM —
TSR TTM (10.56%)
Mkt cap zł 95.70M
ROIC (58.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 2.81
25.29%
(92.64%)
Buy 2|3|7|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.02
0.02
0.02
0.02
1.18%
(0.46%)
1.93%
(2.00%)
Revenuezł M
5.147
5.387
5.610
5.452
2.03%
7.88%
14.04%
11.36%
Peers (US$24.17M)
Cap (US$)
PE
31.51M
—
28.93M
—
28.69M
—
Capital
TTM
5Y
10Y
Leveragex
0.986
(0.061)
(0.053)
EBIT/Intx
0.405
0.059
0.081
Own earn%
(66.66)
(17.64)
(21.66)
Sh yield%
26.85
42.87
41.70
Owners
Insiders/Inst%
13.06
59.44
Short interest%
3.09
SBC / revenue%
3.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
12–18
$1 testx
0.2
Incr. ROIC%
3